22 May 2015

Klaricid Paediatric (Clarithromycin) - United Kingdom

ATC: J01FA
ANTIINFECTIVES FOR SYSTEMIC USE
ANTIBACTERIALS FOR SYSTEMIC USE
MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
MACROLIDES
Klaricid Paediatric Suspension

Generic Matches for Clarithromycin (3)
Klaricid Paediatric Suspension 125mg/5ml
Klaricid Adult Sachet
Klaricid XL tablets

Last Updated on 22 May 2015 by EPG Health Media Staff

Suggest content to an epgonline.org editor - or let us know about a mistake you have spotted on this page

Klaricid Paediatric Suspension Indication

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Klaricid Paediatric Suspension 125mg/5ml is indicated in children 6 months to 12 years.

Klaricid Paediatric Suspension 125mg/5ml is indicated for the treatment of infections caused by susceptible organisms. Indications include:

Lower respiratory tract infections.

Upper respiratory tract infections.

Skin and skin structure infections.

Acute otitis media.

Klaricid Paediatric Suspension 125mg/5ml is usually active against the following organisms in vitro:

Gram-positive Bacteria: Staphylococcus aureus (methicillin susceptible); Streptococcus pyogenes (Group A beta-haemolytic streptococci); alpha-haemolytic streptococci (viridans group); Streptococcus (Diplococcus) pneumoniae; Streptococcus agalactiae; Listeria monocytogenes.

Gram-negative Bacteria: Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella (Branhamella) catarrhalis, Neisseria gonorrhoeae; Legionella pneumophila, Bordetella pertussis, Helicobacter pylori; Campylobacter jejuni.

Mycoplasma: Mycoplasma pneumoniae; Ureaplasma urealyticum.

Other Organisms: Chlamydia trachomatis; Mycobacterium avium; Mycobacterium leprae; Chlamydia pneumoniae.

Anaerobes: Macrolide-susceptible Bacteroides fragilis; Clostridium perfringens; Peptococcus species; Peptostreptococcus species; Propionibacterium acnes.

Klaricid Paediatric Suspension 125mg/5ml has bactericidal activity against several bacterial strains. These organisms include H. influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus agalactiae, Moraxella (Branhamella) catarrhalis, Neisseria gonorrhoeae, Helicobacter pylori and Campylobacter species.

The activity of clarithromycin against H. pylori is greater at neutral pH than at acid pH.

Klaricid Paediatric Suspension Generic Name

Clarithromycin

Type

POM

Summary Product Characteristics (SPCs) Links
All SPC - Klaricid Paediatric Suspension (external site)
SPC - Klaricid Paediatric Suspension 125mg/5ml (external site)
SPC - Klaricid Paediatric Suspension 250mg/5ml (external site)

Related Learning Zones

CSU Knowledge Centre and CME

CSU Knowledge Centre and CME

This Knowledge Centre is intended for allergists, immunologists, dermatologists and other healthcare professionals involved in the treatment and management of Chronic Spontaneous Urticaria (CSU). In the Knowledge Centre, you will find a disease overview, symposium highlights platform, video channel and additional resources including an events calendar and useful external links. This resource has been given a whole new look and feel, intended to improve accessibility and visual appeal. Recent content additions include case studies from urticaria experts Professor Christian Vestergaard and Professor Torsten Zuberbier and information on the TARGET My Hives app.

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

Klaricid Paediatric Marketing Information

Klaricid Paediatric Generic Name
Clarithromycin
Marketing Company
BGP Products Ltd.
Drug Type
POM
Date of Issue, Marketing Authority - Klaricid Paediatric Suspension 125mg/5ml: 16/10/1995

- Klaricid Paediatric Suspension 250mg/5ml: 19/05/1999

Related Drugs - Infectious Diseases

Back to top